Frontiers in Oncology (Dec 2020)
Canadian Pediatric Neuro-Oncology Standards of Practice
- Julie Bennett,
- Craig Erker,
- Lucie Lafay-Cousin,
- Vijay Ramaswamy,
- Juliette Hukin,
- Magimairajan I. Vanan,
- Sylvia Cheng,
- Hallie Coltin,
- Adriana Fonseca,
- Donna Johnston,
- Andrea Lo,
- Shayna Zelcer,
- Saima Alvi,
- Lynette Bowes,
- Josée Brossard,
- Janie Charlebois,
- David Eisenstat,
- Kathleen Felton,
- Adam Fleming,
- Nada Jabado,
- Valérie Larouche,
- Geneviève Legault,
- Chris Mpofu,
- Sébastien Perreault,
- Mariana Silva,
- Roona Sinha,
- Doug Strother,
- Derek S. Tsang,
- Beverly Wilson,
- Bruce Crooks,
- Ute Bartels
Affiliations
- Julie Bennett
- Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada
- Craig Erker
- Division of Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada
- Lucie Lafay-Cousin
- Department of Oncology, Alberta Children’s Hospital, Calgary, AB, Canada
- Vijay Ramaswamy
- Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada
- Juliette Hukin
- Division of Hematology, Oncology and Bone Marrow Transplant, British Columbia Children’s Hospital, Vancouver, BC, Canada
- Magimairajan I. Vanan
- Department of Oncology, University of Manitoba, Winnipeg, MB, Canada
- Sylvia Cheng
- Division of Hematology, Oncology and Bone Marrow Transplant, British Columbia Children’s Hospital, Vancouver, BC, Canada
- Hallie Coltin
- Division of Hematology/Oncology, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
- Adriana Fonseca
- Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada
- Donna Johnston
- Division of Hematology/Oncology, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
- Andrea Lo
- Division of Radiation Oncology and Developmental Radiotherapeutics, BC Cancer Centre, Vancouver, BC, Canada
- Shayna Zelcer
- Division of Pediatric Hematology/Oncology, London Health Sciences Centre, London, ON, Canada
- Saima Alvi
- Pediatric Oncology, Saskatchewan Cancer Agency, Regina, SK, Canada
- Lynette Bowes
- 0Division of Pediatrics, Memorial University, St. John’s, NF, Canada
- Josée Brossard
- 1Division of Pediatric Hematology/Oncology, Universitaire de Sherbrooke, Sherbrooke, QC, Canada
- Janie Charlebois
- 1Division of Pediatric Hematology/Oncology, Universitaire de Sherbrooke, Sherbrooke, QC, Canada
- David Eisenstat
- 2Division of Pediatric Hematology/Oncology & Palliative Care, Stollery Children’s Hospital, Edmonton, AB, Canada
- Kathleen Felton
- 3Division of Pediatric Hematology/Oncology, Jim Pattison Children’s Hospital, Saskatoon, SK, Canada
- Adam Fleming
- 4Division of Pediatric Hematology/Oncology, McMaster Children’s Hospital, Hamilton, ON, Canada
- Nada Jabado
- 5Division of Hematology/Oncology, Montreal Children’s Hospital, Montreal, QC, Canada
- Valérie Larouche
- 6Division of Hematology/Oncology, CHU de Quebec, Quebec City, QC, Canada
- Geneviève Legault
- 5Division of Hematology/Oncology, Montreal Children’s Hospital, Montreal, QC, Canada
- Chris Mpofu
- 3Division of Pediatric Hematology/Oncology, Jim Pattison Children’s Hospital, Saskatoon, SK, Canada
- Sébastien Perreault
- 7Division of Pediatric Neurology, CHU Sainte-Justine, Montreal, QC, Canada
- Mariana Silva
- 8Division of Pediatrics, Queen’s University, Kingston, ON, Canada
- Roona Sinha
- 3Division of Pediatric Hematology/Oncology, Jim Pattison Children’s Hospital, Saskatoon, SK, Canada
- Doug Strother
- Department of Oncology, Alberta Children’s Hospital, Calgary, AB, Canada
- Derek S. Tsang
- 9Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
- Beverly Wilson
- 2Division of Pediatric Hematology/Oncology & Palliative Care, Stollery Children’s Hospital, Edmonton, AB, Canada
- Bruce Crooks
- Division of Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada
- Ute Bartels
- Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada
- DOI
- https://doi.org/10.3389/fonc.2020.593192
- Journal volume & issue
-
Vol. 10
Abstract
Primary CNS tumors are the leading cause of cancer-related death in pediatrics. It is essential to understand treatment trends to interpret national survival data. In Canada, children with CNS tumors are treated at one of 16 tertiary care centers. We surveyed pediatric neuro-oncologists to create a national standard of practice to be used in the absence of a clinical trial for seven of the most prevalent brain tumors in children. This allowed description of practice across the country, along with a consensus. This had a multitude of benefits, including understanding practice patterns, allowing for a basis to compare in future research and informing Health Canada of the current management of patients. This also allows all children in Canada to receive equivalent care, regardless of location.
Keywords
- pediatric neuro-oncology
- standards
- national strategy
- low grade glioma
- high grade glioma
- medulloblastoma
